Skip to Main Content

Paper Details

Association of CDKN2A alterations with increased postoperative seizure risk after resection of brain metastases.
Neurosurg Focus
0
2023
BM, BMs, CDKN2A, Melanoma BMs, Seizures, brain metastases, malignancies, melanoma BMs, melanoma primary malignancy, oncogenes, patients, postoperative seizures, primary malignancies

Datasets

Release 1.2